Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled date : 2022 - 02 - 15 save search
U.S. Food and Drug Administration (FDA) Accepts Mirati Therapeutics' New Drug Application for Adagrasib as Treatment of Previously Treated KRASG12C-Mutated Non-Small Cell Lung Cancer
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 1.42%
H: 5.52%
C: 4.35%
krasg12 new drug treatment fda application drug therapeutics cel food lung cancer cancer fda acceptance
Celularity Receives Orphan Drug Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Development for the First-Line Treatment of Advanced HER2/neu Positive Gastric and Gastroesophageal Junction Cancers
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
CELU F | $3.31 -5.43% -6.22% 35K
|
|
| O: 4.73%
H: 5.21%
C: 3.47%
cynk-101 treatment fda drug drug designation cel orphan drug positive therapy cancer designation her2- her2
PDS Biotech Announces Clinical Trial with Mayo Clinic to Study PDS0101 in Early Stage Pre-Metastatic- HPV-Associated Head and Neck Cancer
Published: 2022-02-15 (Crawled : 14:30) - biospace.com/
PDSB | $2.72 -2.86% -3.32% 610K
|
Health Technology
|
| O: 2.78%
H: 4.42%
C: -1.71%
pds0101 ces hpv trial cancer head and neck biotech iot
Intellia and ONK Therapeutics Announce Collaboration to Advance Allogeneic CRISPR-Edited NK Cell Therapies for the Treatment of Patients with Cancer
Published: 2022-02-15 (Crawled : 14:30) - biospace.com/
NTLA | $21.5 -1.42% -1.35% 830K
|
Health Technology
|
| O: 2.09%
H: 8.24%
C: 6.85%
treatment therapeutics crispr cel intel collaboration cancer
Mustang Bio Announces City of Hope MB-105 Prostate Stem Cell Antigen CAR T Data Selected for Presentation at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium
Published: 2022-02-15 (Crawled : 14:00) - biospace.com/
MBIO | $0.384 10.92% 7.18% 270K
|
Health Technology
|
| O: 1.69%
H: 5.15%
C: 5.15%
FBIO | $1.77 0.57% 1.68% 250K
|
Health Technology
|
| O: 1.09%
H: 2.15%
C: 1.08%
mb-105 america symposium state presentation cel stem cell cancer
Personalis Announces Collaboration with UC San Diego Moores Cancer Center for Clinical Genomic Testing and Research into Composite Biomarkers and Minimal Residual Disease Detection
Published: 2022-02-15 (Crawled : 14:00) - biospace.com/
PSNL | $1.2 -3.23% -3.33% 350K
|
Health Technology
|
| O: 2.42%
H: 1.84%
C: -0.96%
genomic announces collaboration research disease test collaboration cancer biomarkers
Lantern Pharma Expands into Additional Pediatric Cancers Through a Collaboration with The Greehey Children's Cancer Research Institute (GCCRI) at University of Texas Health Science Center-San Antonio
Published: 2022-02-15 (Crawled : 13:00) - biospace.com/
LTRN | $5.99 -0.17% 0.0% 160K
|
Health Technology
|
| O: 1.39%
H: 3.65%
C: 3.65%
health research collaboration cancer children
Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Published: 2022-02-15 (Crawled : 12:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 3.4%
H: 1.1%
C: -7.24%
mridian prostate cancer state trial therapy cancer iot
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
VNDA | News | $5.24 29.38% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.